The impact of high-flow nasal cannula oxygen therapy on exercise capacity in fibrotic interstitial lung disease: a proof-of-concept randomized controlled crossover trial

BACKGROUND: Patients with fibrotic interstitial lung disease (FILD) often experience gas exchange abnormalities and ventilatory limitations, resulting in reduced exercise capacity. High-flow nasal cannula (HFNC) oxygen therapy is a novel treatment, whose physiological beneficial effects have been de...

Full description

Saved in:
Bibliographic Details
Published in:BMC Pulm Med
Main Authors: Suzuki, Atsushi, Ando, Masahiko, Kimura, Tomoki, Kataoka, Kensuke, Yokoyama, Toshiki, Shiroshita, Eiichi, Kondoh, Yasuhiro
Format: Artigo
Language:Inglês
Published: BioMed Central 2020
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7041255/
https://ncbi.nlm.nih.gov/pubmed/32093665
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12890-020-1093-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items